Which investor group is most to blame for Symbiotec Pharmalab's stumble?

Symbiotec Pharmalab has seen its share price plummet by over 6% in a single day, leaving investors wondering who will be blamed for the stock's collapse. The company's shares fell to Rs 968.40 on the Bombay Stock Exchange (BSE) today, marking a discount of 1.98%. Who is most like

• Option 1: The insiders at pharma giant Akshi Biotech0%
• Option 2: Symbiotec Pharmalab's own management team0%